www.fdanews.com/articles/156780-takeda-announces-withdrawal-of-marketing-authorization-application-for-peginesatide-injection-in-europe

Takeda Announces Withdrawal of Marketing Authorization Application for Peginesatide Injection in Europe

July 1, 2013

Takeda’s European subsidiary, Takeda Development Centre Europe, has withdrawn its marketing authorization application for injectable peginesatide solution, aimed at treating anemia in patients with kidney disease.
Takeda